LONSURF

NDC 64842-1025 · Taiho Pharmaceutical Co., Ltd.

Generic nametrifluridine and tipiracil

Dosage formTABLET, FILM COATED

RouteORAL

Active ingredient(s)TRIFLURIDINE, TIPIRACIL HYDROCHLORIDE

Strength6.14; 15 mg/1; mg/1

Pharmacologic classNucleic Acid Synthesis Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT], Nucleoside Metabolic Inhibitor [EPC], Thymidine Phosphorylase Inhibitor [EPC], Thymidine Phosphorylase Inhibitors [MoA]

Marketing categoryNDA

Packages

64842-1025-1 — 20 TABLET, FILM COATED in 1 BOTTLE (64842-1025-1)

64842-1025-2 — 40 TABLET, FILM COATED in 1 BOTTLE (64842-1025-2)

64842-1025-3 — 60 TABLET, FILM COATED in 1 BOTTLE (64842-1025-3)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

61314-044 — trifluridine, 64842-1020 — trifluridine and tipiracil

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels